Drug class:Dipeptidyl peptidase 4 inhibitors Medically reviewed bySanjai Sinha, MD. Last updated on Jun 10, 2024. What is Tradjenta? Tradjenta is anoral diabetes medicinethat helps control blood sugar levels. It works by regulating the levels of insulin your body produces after eating. ...
DRUG INTERACTIONS:The efficacy of TRADJENTA may be reduced when administered in combination with a strong P-gp or CYP3A4 inducer. Alternative treatments should be used. USE IN SPECIFIC POPULATIONS:Use during pregnancy only if clearly needed. Exercise caution when administering to a nursing woman. ...
Google Share on Facebook linagliptin (redirected fromTradjenta) Medical lin·a·glip·tin (lĭn′ə-glĭp′tn) n. An oral hypoglycemic drug, C25H28N8O2, used to treat type 2 diabetes. [lina-,of unknown origin+-gliptin,hypoglycemic drug suffix; seesaxagliptin.] ...
The article offers information on the drug, Tradjenta, produced by Boehringer Ingelheim GmbH and Eli Lilly and Co. The product comes under the pharmacologic class of dipeptidyl peptidase-4 inhibitor, with linagliptin being an active ingredient....
Inform patients that severe and disabling joint pain may occur with this class of drugs. The time to onset of symptoms can range from one day to years. Instruct patients to seek medical advice if severe joint pain occurs. Bullous Pemphigoid Inform patients that bullous pemphigoid may occur with...